How SSA Evaluates Multiple Sclerosis for SSDI

Yes, people with multiple sclerosis (MS) qualify for Social Security Disability Insurance (SSDI), and SSA evaluates the disease under Blue Book Listing 11.09. A claim succeeds either by showing disorganization of motor function in two extremities, or by showing marked limitation in physical functioning combined with a marked limitation in one area of mental functioning.

MS is unusual among neurological listings because of how it fluctuates. Section 11.00N1 of 20 CFR Part 404, Subpart P, Appendix 1, describes forms ranging from mild attacks with full recovery to aggressive disease with steady progression and no remissions. The multiple sclerosis SSDI criteria were built to capture function across that whole range rather than to match a specific disease course.

Where Listing 11.09 Came From

SSA rewrote the neurological listings in a final rule published at 81 FR 43048, effective September 29, 2016. That rule replaced symptom-based criteria with the functional structure still in force, which measures what MS actually prevents a person from doing rather than naming required signs.

Section 11.00N1 defines MS as a chronic, inflammatory, degenerative disorder that damages the myelin sheath surrounding nerve fibers in the brain and spinal cord, disrupting nerve transmission and impairing muscle coordination, strength, balance, sensation, and vision.

Path A: Disorganization of Motor Function in Two Extremities

Listing 11.09A requires disorganization of motor function in two extremities, resulting in an extreme limitation in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities.

Section 11.00D1 defines two extremities as both lower extremities, both upper extremities, or one upper and one lower extremity. Section 11.00D2 defines extreme limitation concretely:

• Inability to stand from seated means you cannot stand and maintain an upright position without another person's help or an assistive device such as a walker, two crutches, or two canes.
• Inability to maintain balance means you cannot stay upright while standing or walking without another person or such a device.
• Inability to use the upper extremities means loss of function in both arms that very seriously limits fine movements such as pinching and manipulating, or gross movements such as gripping, holding, reaching, lifting, and carrying.

Meeting 11.09A approves the claim at Step 3 of the sequential evaluation under 20 CFR 404.1520(d), without any vocational analysis.

Path B: Marked Physical and Mental Limitations

Listing 11.09B is the route most MS claimants who do not use wheelchairs must satisfy. It requires a marked limitation in physical functioning and a marked limitation in at least one of the four areas of mental functioning defined in section 11.00G3b.

• Understanding, remembering, or applying information, such as learning procedures and following multi-step instructions.
• Interacting with others, including supervisors, co-workers, and the public.
• Concentrating, persisting, or maintaining pace, meaning sustained attention and timely task completion.
• Adapting or managing oneself, covering emotional regulation and awareness of hazards.

Section 11.00G2 explains that marked is the fourth point on a five-point scale running from no limitation to extreme limitation, and that it does not require confinement to bed or a nursing home.

Physical functioning under section 11.00G3a covers standing up, balancing, walking, and using both upper extremities, but it also covers body functions supporting those abilities, such as seeing, breathing, and swallowing. A combination of limitations can together rise to marked.

How Fatigue Fits the Analysis

Fatigue is often the decisive symptom in an MS claim, and the regulations address it directly. Section 11.00T states that fatigue is one of the most common and limiting symptoms of disorders including MS, and distinguishes physical fatigue, a lack of muscle strength, from mental fatigue, decreased awareness or attention.

SSA considers the intensity, persistence, and effects of fatigue on functioning, drawing on clinical and laboratory data, a description of fatigue characteristic of the disorder, and information about daily functioning. Section 11.00G3a specifically instructs SSA to count symptoms such as pain or fatigue, documented in the medical record and caused by the disorder or its treatment, when measuring physical functioning.

Section 11.00N2 adds the secondary symptoms SSA weighs under Path B, including impaired attention, concentration, memory, or judgment, trouble sleeping, mood swings, and depression. Vision loss from MS is evaluated separately under the special senses listings in section 2.00.

Exacerbations, Remissions, and Treatment Effects

MS moves in cycles, and the rules account for that. Section 11.00G4a directs SSA to consider whether signs and symptoms are persistent or intermittent, how often they occur, how long they last, how intense they are, and whether there are periods of exacerbation and remission.

Section 11.00G4b covers treatment. SSA weighs medication side effects, dosing schedules, injections, the intrusiveness and duration of treatment, variability in response, and drug interactions. Notably, Listing 11.09 carries no formal adherence requirement, unlike the epilepsy and Parkinsonian syndrome listings. Section 11.00C requires documented adherence to prescribed treatment only for Listings 11.02, 11.06, and 11.12.

If the Listing Is Not Met: The RFC and Grid Analysis

Falling short of Listing 11.09 is not the end of the claim. SSA then assesses residual functional capacity under 20 CFR 404.1545, the most a person can sustain in an 8-hour workday and 5-day week.

MS commonly produces limits that erode both sedentary and light work, including reduced standing and walking tolerance, a need to alternate sitting and standing, decreased grip and manipulation, fatigue that requires rest beyond normal breaks, and visual or cognitive limits on machine-paced work.

At Step 4, past relevant work is now work performed within the past 5 years, following the 2024 change reflected in SSR 24-2p and 20 CFR 404.1560(a)(1). At Step 5, the medical-vocational guidelines in 20 CFR Part 404, Subpart P, Appendix 2 apply. Under Rule 201.12 or Rule 201.14, a claimant age 50 to 54 limited to sedentary work without transferable skills is found disabled, and under Rule 201.06 the same is true at age 55 and older. Younger claimants must generally show that fatigue and other non-exertional limits preclude even unskilled sedentary work.

Non-Medical Requirements in 2026

The 12-month duration requirement of 20 CFR 404.1509 applies to MS as to every impairment. In 2026, substantial gainful activity under 20 CFR 404.1574 means gross monthly earnings above $1,690 for non-blind individuals and above $2,830 for statutorily blind individuals, per the SSA amounts published for 2026. Insured status under 20 CFR 404.130 generally requires 20 work credits earned in the 10 years ending with the year disability began.

Filing mechanics and appeals belong to separate resources and are outside the scope of this article.

Building the Medical Record

Strong MS files usually include neurologist treatment notes over time, MRI and other imaging reports, medication and infusion records showing treatment response and side effects, walking and balance observations at each visit, and statements from family members or former supervisors describing fatigue, falls, and cognitive changes between appointments. Because section 11.00G4a requires attention to pattern over time, a longitudinal record matters more than any single examination.

Frequently Asked Questions

Can you qualify for SSDI with multiple sclerosis without using a wheelchair? Yes. Listing 11.09B does not require an assistive device. It is met with a marked limitation in physical functioning plus a marked limitation in one of four areas of mental functioning, such as concentrating, persisting, or maintaining pace.

Does fatigue count when SSA evaluates multiple sclerosis? Yes. Section 11.00T states that fatigue is one of the most common and limiting symptoms of multiple sclerosis, and section 11.00G3a directs SSA to count documented fatigue when it assesses both physical and mental functioning.

Is there a treatment adherence requirement for MS under Listing 11.09? No. Unlike epilepsy under 11.02 and Parkinsonian syndrome under 11.06, Listing 11.09 has no formal adherence requirement. Section 11.00G4b instead requires SSA to weigh how your treatment affects your functioning.

This article is general information about Social Security Disability Insurance eligibility, not legal advice. Program rules, earnings limits, and evaluation standards change over time, and every situation is different. Consult a qualified representative or contact the Social Security Administration directly for guidance on your specific claim.